Search

everythinglearnresearchcommunity

for

Search:↓

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Spironolactone is a safe and effective hair loss treatment, especially with minoxidil.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Deoxycorticosterone and its metabolites help prevent seizures by interacting with specific receptors.

A woman's hair turned white after taking a cancer drug called dasatinib.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

Combining low-dose oral minoxidil and spironolactone may improve hair growth safely.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

The method effectively measures drug impact on DHT levels in prostate treatments.

Tiny particles carrying roxithromycin can effectively target and deliver the drug to hair follicles without irritation.

Taking dutasteride every other day works as well as daily and better preserves sexual function.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Spironolactone may be a better acne treatment for adult women than antibiotics.

Dutasteride helps hair growth in those unresponsive to finasteride, but may cause more sexual dysfunction.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Finasteride, a medication, is being re-evaluated for its effects and uses.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.